The Pilot-to-Protocol™ Method
Most MedTech ventures don’t fail because the technology is weak. They fail because they scale before they’ve proven they should.
In MedTech, the ultimate goal isn’t just growth.
The goal is to become the protocol.
When a technology moves from “nice to have” to “standard of care,” adoption accelerates, reimbursement becomes more predictable, and the company gains a commanding market position. Most founders and advisors skip the hard work of proving product-market fit before pushing for scale. The result? Stalled adoption, wasted capital, and painful pivots.
We developed the Pilot-to-Protocol™ Method to solve this exact problem. It’s a structured, MedTech-specific operating system that begins with rigorous product-market fit diagnosis and guides companies through four deliberate stages, with the ultimate goal to become the standard of care.
Exploratory
We begin with a structured diagnostic to assess your current product-market fit, identify the specific gaps between perceived and actual fit, and prioritize the highest-leverage actions to close them.
Formative
Once product-market fit is in sight, we help you design and implement the foundational go-to-market strategy, messaging, and early commercial plays that can actually scale.
Accelerating
We work with you to build health-system partnerships, refine your commercialization engine, and install the processes and data infrastructure needed for predictable growth.
Commanding
Finally, we help you build the leadership, systems, and organizational discipline required to move from strong player to the standard of care.
Pilot to Protocol.
This isn’t a generic growth playbook.
It’s a MedTech-specific methodology built for the realities of regulatory pathways, reimbursement, long sales cycles, and capital constraints — designed to take you all the way to becoming the standard of care.
The companies that win in MedTech aren’t necessarily the ones with the best technology or the best early sales skills. They’re the ones that methodically close the gap between pilot success and real product-market fit — and then build the operating discipline to become the protocol everyone else follows.